Precision medicine is an approach to healthcare that tailors prevention, diagnosis and treatment to the individual characteristics of each patient. Instead of relying on average responses in large populations, it uses detailed biological information to guide clinical decisions.

A central pillar is genomic profiling. By sequencing a patient’s DNA, clinicians can identify mutations that drive disease, especially in cancer. Targeted therapies are then chosen to block the specific molecular pathways involved. This has transformed the treatment of certain leukemias, lung cancers and breast cancers, where drugs directed at defined genetic alterations can dramatically improve outcomes and reduce side effects.

Beyond genetics, precision medicine integrates data on RNA expression, proteins, metabolites and the immune system. For example, biomarkers can predict which patients are likely to respond to immunotherapy, while pharmacogenomic markers help determine safe and effective drug doses. In rare diseases, sequencing can reveal causal mutations, enabling more accurate diagnosis and, in some cases, personalized experimental therapies.

Large biobanks and national initiatives collect genomic and clinical data from hundreds of thousands of volunteers. These resources support discovery of new disease genes, risk scores for common conditions and strategies for earlier detection. Artificial intelligence methods are increasingly used to analyze complex datasets and uncover patterns that guide more individualized care.

Key challenges include data privacy, equitable access, interpretation of variants and integration into routine practice. Nonetheless, the accumulated research demonstrates that precision medicine can improve patient outcomes and move healthcare toward more predictive, preventive and personalized models.